Device Trial Radar · NCT02376829
Class II Correction Study Using the Invisalign System
Last checked: Nov 19, 2026Latest source record: May 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
164
Actual
Start
Mar 2015
Primary completion
Nov 23, 2021
Study completion Nov 23, 2021
Sponsor
- Lead sponsor
- Align Technology, Inc.Public (ALGN)
- Sponsor type
- Industry
- First posted
- Mar 3, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 11 years, up to 19 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To demonstrate that growing teenagers which present up to full cusp Class II malocclusions can be treated using the Invisalign System.
Conditions
- Malocclusion
Interventions
Invisalign SystemDevice
The Invisalign® System is indicated for the alignment of teeth during orthodontic treatment of malocclusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of Tooth Movement at the End of Class II Correction.Time frame: End of Class II Correction up to 18 months
Locations
10 sites in 2 countries. Site status is shown where the registry gives one.
Dr. Gary Brigham
Scottsdale, Arizona
Dr. Donna Galante
Rocklin, California
Dr. Mark Holt
Roseville, California
7 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.